Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Langsted

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|December 9, 2020
Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort studyCamilla Ditlev Lindhardt Johannesen, Anne Langsted, Martin Bødtker Mortensen, et al.
Journal of the American College of Cardiology|March 19, 2021
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated PatientsCamilla Ditlev Lindhardt Johannesen, Martin Bødtker Mortensen, Anne Langsted, et al.
Annals of Neurology|May 31, 2022
ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke RiskCamilla D L Johannesen, Martin B Mortensen, Anne Langsted, et al.
JAMA Cardiology|May 13, 2026
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular DiseaseCamilla Ditlev Lindhardt Johannesen, Anne Langsted, Børge Grønne Nordestgaard, et al.
Atherosclerosis|March 12, 2025
Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimationCamilla Ditlev Lindhardt Johannesen, Martin Bødtker Mortensen, Børge Grønne Nordestgaard, et al.
The Lancet. Diabetes & Endocrinology|May 18, 2016
High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort studyAnne Langsted, Pia R Kamstrup, Marianne Benn, et al.
Heart (British Cardiac Society)|May 14, 2026
Lipid-related cardiovascular risk beyond low-density lipoprotein cholesterolMie Balling, Karen Hvid, Anette Varbo, et al.
Atherosclerosis|October 22, 2024
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide studySofie B Simony, Anne Langsted, Martin B Mortensen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2016
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve StenosisAnne Langsted, Børge G Nordestgaard, Marianne Benn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2019
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based StudyChristian M Madsen, Pia R Kamstrup, Anne Langsted, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|December 9, 2020
Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort studyCamilla Ditlev Lindhardt Johannesen, Anne Langsted, Martin Bødtker Mortensen, et al.
Journal of the American College of Cardiology|March 19, 2021
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated PatientsCamilla Ditlev Lindhardt Johannesen, Martin Bødtker Mortensen, Anne Langsted, et al.
Annals of Neurology|May 31, 2022
ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke RiskCamilla D L Johannesen, Martin B Mortensen, Anne Langsted, et al.
JAMA Cardiology|May 13, 2026
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular DiseaseCamilla Ditlev Lindhardt Johannesen, Anne Langsted, Børge Grønne Nordestgaard, et al.
Atherosclerosis|March 12, 2025
Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimationCamilla Ditlev Lindhardt Johannesen, Martin Bødtker Mortensen, Børge Grønne Nordestgaard, et al.
The Lancet. Diabetes & Endocrinology|May 18, 2016
High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort studyAnne Langsted, Pia R Kamstrup, Marianne Benn, et al.
Heart (British Cardiac Society)|May 14, 2026
Lipid-related cardiovascular risk beyond low-density lipoprotein cholesterolMie Balling, Karen Hvid, Anette Varbo, et al.
Atherosclerosis|October 22, 2024
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide studySofie B Simony, Anne Langsted, Martin B Mortensen, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2016
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve StenosisAnne Langsted, Børge G Nordestgaard, Marianne Benn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2019
Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based StudyChristian M Madsen, Pia R Kamstrup, Anne Langsted, et al.
Pageof 8